Oppenheimer Upgrades CymaBay Therapeutic (CBAY) to Outperform
Tweet Send to a Friend
Oppenheimer analyst Jay Olson upgraded CymaBay Therapeutic (NASDAQ: CBAY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
